Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New rapid test could slash antibiotic misuse in hospital pneumonia

NCT ID NCT04153682

Diagnosis Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Aug 13, 2026 · Updated 3 times

Summary

This study tested whether a fast diagnostic test (FilmArray) plus expert antibiotic advice improves care for patients who develop pneumonia in the hospital. 116 adults with hospital-acquired pneumonia were randomly assigned to get either standard care with expert advice or the same plus the rapid test. The goal was to see if the rapid test helps doctors use fewer broad-spectrum antibiotics and improve patient outcomes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Rapid diagnostic test (FilmArray Pneumonia Panel) and antimicrobial stewardship team intervention
What this could lead to
If successful, this approach could help doctors choose the right antibiotics faster, reducing side effects and antibiotic resistance.
What could go wrong
This is a small, completed trial with 116 patients, so results may not apply to all hospitals or patients. The test may not always be accurate.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

116 people

The number who actually took part.

Started

Feb 2020

Finished

Aug 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Any patient hospitalized for ≥ 48 hours * aged 18 years or older * not mechanically-ventilated at time of onset of pneumonia symptoms * Dated and signed inform consent - written informed consent of relative (trusted person, close family) in case of emergency procedure, by default emergency inclusion notified in medical file and pursuance consent sought * Affiliation with a social security scheme Criteria of pneumonia: * New lung infiltrate on a chest-x ray plus * Evidence that the infiltrate is of an infectious origin, i.e. new onset of fever (\> 38.5°C) and/or purulent sputum and/or leukocytosis and/or decline in oxygenation Exclusion Criteria: * Patients with severe chronic bronchitis structural changes: very severe COPD (Global initiative for chronic Obstructive Lung Disease GOLD 4), cystic fibrosis * Radiological evidence of thoracic empyema, pulmonary abcess * Patient life expectancy \< 90 days

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hospital-acquired pneumonia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Healthcare-Associated Pneumonia nosocomial infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hospital-acquired pneumonia

Contacts and locations

Locations

  • CHRU Nancy

    Nancy, 54511, France

  • Groupe Hospitalier Paris Saint Joseph

    Paris, 75014, France

  • Hôpitaux Universitaires Henri Mondor

    Créteil, 94010, France

  • Hôpitaux Universitaires Paris Centre (Cochin) - service Médecine Intensive - Réanimation

    Paris, 75006, France

  • Hôpitaux Universitaires Paris Centre-Site Cochin

    Paris, 75014, France

  • Hôpitaux Universitaires Paris Nord Val de Seine - EPRI (Bichat)

    Paris, France

  • Hôpitaux Universitaires Paris Nord Val de Seine - MIR (Bichat)

    Paris, France

  • Hôpitaux Universitaires Paris Nord Val de Seine-Site Bichat (SMIT)

    Paris, 75018, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.